Literature DB >> 26424420

The exclusion of people with psychiatric disorders from medical research.

Keith Humphreys1, Janet C Blodgett2, Laura Weiss Roberts3.   

Abstract

People with psychiatric disorders are excluded from medical research to an unknown degree with unknown effects. We examined the prevalence of reported psychiatric exclusion criteria using a sample of 400 highly-cited randomized trials (2002-2010) across 20 common chronic disorders (6 psychiatric and 14 other medical disorders). Two coders rated the presence of psychiatric exclusion criteria for each trial. Half of all trials (and 84% of psychiatric disorder treatment trials) reported possible or definite psychiatric exclusion criteria, with significant variation across disorders (p < .001). Non-psychiatric conditions with high rates of reported psychiatric exclusion criteria included low back pain (75%), osteoarthritis (57%), COPD (55%), and diabetes (55%). The most commonly reported type of psychiatric exclusion criteria were those related to substance use disorders (reported in 48% of trials reporting at least one psychiatric exclusion criteria). General psychiatric exclusions (e.g., "any serious psychiatric disorder") were also prevalent (38% of trials). Psychiatric disorder trials were more likely than other medical disorder trials to report each specific type of psychiatric exclusion (p's < .001). Because published clinical trial reports do not always fully describe exclusion criteria, this study's estimates of the prevalence of psychiatric exclusion criteria are conservative. Clinical trials greatly influence state-of-the-art medical care, yet individuals with psychiatric disorders are often actively excluded from these trials. This pattern of exclusion represents an under-recognized and worrisome cause of health inequity. Further attention should be paid to how individuals with psychiatric disorders can be safely included in medical research to address this important clinical and social justice issue. Published by Elsevier Ltd.

Entities:  

Keywords:  Ethics; External validity; Generalizability; Psychiatric exclusion criteria; Randomized trials; Systematic review

Mesh:

Year:  2015        PMID: 26424420     DOI: 10.1016/j.jpsychires.2015.08.005

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  11 in total

1.  Receptiveness to participation in genetic research: A pilot study comparing views of people with depression, diabetes, or no illness.

Authors:  Laura Weiss Roberts; Jane Paik Kim
Journal:  J Psychiatr Res       Date:  2017-07-04       Impact factor: 4.791

2.  Expanding Access to Cancer Clinical Trials for Patients With Mental Illness.

Authors:  Kelly E Irwin; Beverly Moy; Lauren E Fields; Catherine A Callaway; Elyse R Park; Lori Wirth
Journal:  J Clin Oncol       Date:  2019-04-15       Impact factor: 44.544

3.  Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.

Authors:  Kelly E Irwin; Naomi Ko; Elizabeth P Walsh; Veronica Decker; Isabel Arrillaga-Romany; Scott R Plotkin; Jeffrey Franas; Emily Gorton; Beverly Moy
Journal:  Oncologist       Date:  2022-07-05       Impact factor: 5.837

4.  Are diabetes self-management programmes for the general diabetes population effective for people with severe mental illness?: a systematic review.

Authors:  Anne Coxon; Hayley McBain; Neli Pavlova; Hannah Rowlands; Kathleen Mulligan
Journal:  BMC Psychiatry       Date:  2020-07-25       Impact factor: 3.630

5.  Weight change, cardio-metabolic risk factors and cardiovascular incidence in people with serious mental illness: protocol of a population-based cohort study in the UK from 1998 to 2020.

Authors:  Paul Aveyard; Carmen Piernas; Charlotte Lee; Felicity Waite; Margaret C Smith; Min Gao; Clare Bankhead
Journal:  BMJ Open       Date:  2021-11-03       Impact factor: 2.692

6.  Applying Genetic and Genomic Tools to Psychiatric Disorders: A Scoping Review.

Authors:  Ana S IItis; Akaya Lewis; Sarah Neely; Stephannie Walker Seaton; Sarah H Jeong
Journal:  HEC Forum       Date:  2021-11-30

7.  Long-Term Cost-Effectiveness of Smoking Cessation Interventions in People With Mental Disorders: A Dynamic Decision Analytical Model.

Authors:  Qi Wu; Simon Gilbody; Jinshuo Li; Han-I Wang; Steve Parrott
Journal:  Value Health       Date:  2021-06-03       Impact factor: 5.725

8.  Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness.

Authors:  Jayati Das-Munshi; Maya Semrau; Corrado Barbui; Neerja Chowdhary; Petra C Gronholm; Kavitha Kolappa; Dzmitry Krupchanka; Tarun Dua; Graham Thornicroft
Journal:  BMC Psychiatry       Date:  2020-05-14       Impact factor: 3.630

9.  Sahaj Samadhi Meditation versus a Health Enhancement Program for depression in chronic pain: protocol for a randomized controlled trial and implementation evaluation.

Authors:  Abhimanyu Sud; Michelle L A Nelson; Darren K Cheng; Alana Armas; Kirk Foat; Michelle Greiver; Fardous Hosseiny; Joel Katz; Rahim Moineddin; Benoit H Mulsant; Ronnie I Newman; Leon Rivlin; Akshya Vasudev; Ross Upshur
Journal:  Trials       Date:  2020-04-07       Impact factor: 2.279

10.  Prevalence Rates and Evolution of Psychiatric Disorders Among Incarcerated Youths in Comparison With Non-incarcerated Youths.

Authors:  Patrick Heller; Larisa Morosan; Deborah Badoud; Manon Laubscher; Lisa Jimenez Olariaga; Martin Debbané; Hans Wolff; Stéphanie Baggio
Journal:  Front Psychiatry       Date:  2022-01-07       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.